litlas
Log inCreate account

S. B. Kim

Active 1987–2025

Also published as
S.B. Kim · S.-B. Kim · S-B. Kim · S B Kim · S.B Kim · S -B Kim
92
Papers
31,224
Citations
65
h-index
90
i10-index

Citations

Citations per year for S. B. Kim1929: 1 citations1986: 2 citations1987: 2 citations1988: 8 citations1989: 6 citations1990: 9 citations1991: 2 citations1992: 7 citations1993: 8 citations1994: 8 citations1995: 15 citations1996: 12 citations1997: 13 citations1998: 32 citations1999: 66 citations2000: 63 citations2001: 56 citations2002: 92 citations2003: 82 citations2004: 84 citations2005: 50 citations2006: 57 citations2007: 55 citations2008: 51 citations2009: 53 citations2010: 57 citations2011: 55 citations2012: 79 citations2013: 56 citations2014: 40 citations2015: 54 citations2016: 66 citations2017: 88 citations2018: 95 citations2019: 155 citations2020: 263 citations2021: 433 citations2022: 415 citations2023: 323 citations2024: 450 citations2025: 234 citations2026: 8 citations1930–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,172 citing papers, 17.2% of this breakdownChina: 608 citing papers, 8.9% of this breakdownItaly: 439 citing papers, 6.4% of this breakdownGermany: 384 citing papers, 5.6% of this breakdownSpain: 340 citing papers, 5% of this breakdownFrance: 310 citing papers, 4.6% of this breakdownUnited Kingdom: 304 citing papers, 4.5% of this breakdownJapan: 290 citing papers, 4.3% of this breakdownCanada: 233 citing papers, 3.4% of this breakdownSwitzerland: 222 citing papers, 3.3% of this breakdownSouth Korea: 211 citing papers, 3.1% of this breakdownBelgium: 172 citing papers, 2.5% of this breakdown
0%17.2%Other 31.2%

Institutions

Fields

  • Medicine44.3%
  • Physics and Astronomy20.4%
  • Biochemistry, Genetics and Molecular Biology13%
  • Environmental Science9.7%
  • Materials Science3.5%
  • Agricultural and Biological Sciences2.5%
  • Other6.6%

Topics

  • Advanced Breast Cancer Therapies5.4%
  • Neutrino Physics Research5%
  • HER2/EGFR in Cancer Research4.8%
  • Breast Cancer Treatment Studies4.7%
  • Particle physics theoretical and experimental studies4.6%
  • Cancer Immunotherapy and Biomarkers4.2%
  • Other71.3%

Coauthors

All papers

Open in search
  1. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

    Authors: Fátima Cardoso, Shani Paluch–Shimon, Elżbieta Senkus, Giuseppe Curigliano, Matti Aapro, Fabrice André, C.H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Frances Boyle, Maria João Cardoso, L.A. Carey, Javier Cortés, Nagi S. El Saghir, Mona Elzayat, Alexandru Eniu, Lesley Fallowfield, Prudence A. Francis, Karen A. Gelmon, Joseph Gligorov, Renate Haidinger, Nadia Harbeck, Xin Hu, Bella Kaufman, Rajneesh Kaur, Belinda E. Kiely, S.-B. Kim, NU Lin, Shirley Mertz, Silvia P. Neciosup, B.V. Offersen, Shinji Ohno, Olivia Pagani, A. Prat, Frédérique Penault‐Llorca, Hope S. Rugo, G. W. Sledge, Christoph Thomssen, D.A. Vorobiof, Theresa Wiseman, Binghe Xu, Larry Norton, A. Costa, Eric P. Winer - Annals of Oncology 2020 cited by 1,356

  2. Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

    Authors: Peter Schmid, Roberto Salgado, Y.H. Park, Eva Muñoz‐Couselo, S.B. Kim, Joohyuk Sohn, Seock‐Ah Im, Theodoros Foukakis, Sherko Küemmel, Rebecca Dent, L. Yin, A. Wang, Konstantinos Tryfonidis, Vassiliki Karantza, Javier Cortés, Sherene Loi - Annals of Oncology 2020 cited by 435

  3. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

    Authors: Nadia Harbeck, Priya Rastogi, Miguel Martín, Sara M. Tolaney, Zhimin Shao, Peter A. Fasching, Chiun‐Sheng Huang, Georgina Garnica Jaliffe, A. Tryakin, Matthew P. Goetz, Hope S. Rugo, Elżbieta Senkus, Laura Testa, Mariette Andersson, Kenji Tamura, Lucia Del Mastro, Guenther G. Steger, Hans Kreipe, Roberto Hegg, Joohyuk Sohn, Valentina Guarneri, Javier Cortés, E.P. Hamilton, Valérie André, Ran Wei, Susana Barriga, S. Sherwood, Tammy Forrester, Montserrat Muñoz-Mateu, Ashwin Shahir, Belén San Antonio, Sarah C. Nabinger, Masakazu Toi, Stephen Johnston, Joyce O’Shaughnessy, M.M. Jimenez, Stephen Johnston, F. Boyle, Guenther G. Steger, Patrick Neven, Zefei Jiang, Mario Campone, Jens Huober, Chikako Shimizu, I. Cicin, Andrew Wardley, Sara M. Tolaney, Gonzalo Gómez Abuin, J. J. Zarba, Elgene Lim, P. Sant, Naishun Liao, Bo Christiansen, Natalja Eigėlienė, J. Martin-Babau, Johannes Ettl, D. Mavroudis, Joanne Chiu, Katalin Boér, R. Nagarkar, Shani Paluch–Shimon, Luca Moscetti, Yoshiatsu Sagara, S.-B. Kim, Rui M. B. Maciel, Vivianne C. G. Tjan‐Heijnen, Reuben Broom, Aleksandra Łacko, M. Schenker, Nikita Volkov, Yoon Sim Yap, M.A. Coccia-Portugal, J. Ángel García Sáenz, Anne Andersson, Tai-Jong Chao, Erhan Gökmen, Hakan Harputluoğlu, O. Berzoy, Debra A. Patt, Heather L. McArthur, Helen K. Chew, Pavani Chalasani, Peter A. Kaufman, Karen L. Tedesco, Stephanie L. Graff - Annals of Oncology 2021 cited by 378

  4. Validation of SMAP surface soil moisture products with core validation sites

    Authors: Andreas Colliander, Thomas J. Jackson, Rajat Bindlish, S. Chan, Narendra N. Das, S.B. Kim, Michael H. Cosh, R. S. Dunbar, L. Dang, L. Pashaian, Jun Asanuma, K. Aida, Aaron Berg, Tracy Rowlandson, David D. Bosch, Todd G. Caldwell, K. K. Caylor, David C. Goodrich, Hala Al Jassar, Ernesto López-Baeza, José Martínez‐Fernández, Ángel González‐Zamora, Stanley Livingston, Heather McNairn, A. Pacheco, Mahta Moghaddam, Carsten Montzka, Claudia Notarnicola, Georg Niedrist, Thierry Pellarin, John H. Prueger, Jouni Pulliainen, Kimmo Rautiainen, Judith Ramos, M. S. Seyfried, Patrick J. Starks, Zhongbo Su, Yijian Zeng, R. van der Velde, M. Thibeault, Wouter Dorigo, Mariëtte Vreugdenhil, Jeffrey P. Walker, Xiaoling Wu, A. Monerris, Peggy O’Neill, Dara Entekhabi, E. G. Njoku, Simon Yueh - Remote Sensing of Environment 2017 cited by 739

  5. ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

    Authors: Shani Paluch–Shimon, Fátima Cardoso, Ann H. Partridge, Omalkhair Abulkhair, Hatem A. Azim, G. Bianchi-Micheli, Maria João Cardoso, Giuseppe Curigliano, Karen A. Gelmon, Oreste ­Gentilini, Nadia Harbeck, Bella Kaufman, S.B. Kim, Q. Liu, J. Merschdorf, Philip Poortmans, Giancarlo Pruneri, Elżbieta Senkus, Bhawna Sirohi, Tanja Španič, Virpi Sulosaari, Fedro A. Peccatori, Olivia Pagani - Annals of Oncology 2022 cited by 218

  6. Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)

    Authors: Cristina Saura, Shanu Modi, Ian E. Krop, Y.H. Park, S.-B. Kim, Kenji Tamura, Hitoshi Iwata, Junji Tsurutani, Joohyuk Sohn, E. Mathias, Y. Liu, Jillian Cathcart, Jasmeet Singh, Toshinari Yamashita - Annals of Oncology 2023 cited by 108

  7. Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy

    Authors: J H Park, Sarah Flora Jonas, Guillaume Bataillon, Carmen Criscitiello, Roberto Salgado, Sherene Loi, Giuseppe Viale, Heon‐Jin Lee, Maria Vittoria Dieci, S -B Kim, Anne Vincent‐Salomon, Giuseppe Curigliano, Fabrice André, Stefan Michiels - Annals of Oncology 2019 cited by 266

  8. Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

    Authors: Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong, M-J. Ahn, Wan Qin Chong, S. B. Kim, Gwo Fuang Ho, Priscilla B. Caguioa, Nuttapong Ngamphaiboon, Cheryl Ho, Mubashir Aziz, Quan Sing Ng, C-J. Yen, Nopadol Soparattanapaisarn, Roger KC Ngan, S.K. Kho, M.L.A. Tiambeng, Tak Yun, Virote Sriuranpong, Alain P. Algazi, Andy S. K. Cheng, Erminia Massarelli, Ramona F. Swaby, Sanatan Saraf, Jianda Yuan, Lillian L. Siu - Annals of Oncology 2022 cited by 107

  9. Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

    Authors: Miguel Martín, Elgene Lim, Mariana Chávez‐MacGregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, R. N. Safin, Sung‐Bae Kim, Christian Schem, Alberto J. Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M. Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Perez-Moreno, Joohyuk Sohn, for the acelERA Breast Cancer Study Investigators, G. Aguil, Marcos E. Alfie, Valeria Cáceres, Guillermo Lerzo, Sandra A. Ostoich, F. Boyle, Elgene Lim, Hayes Martin, Catherine Oakman, Felipe Melo Cruz, Fábio Franke, André Mattar, E.H. Silva, Katsuki Arima Tiscoski, Wei Chen, Wěi Li, Zhongsheng Tong, Jing Wang, Shaomeng Wang, X. Wang, Jiong Wu, Xiao‐Yuan Wu, Ju Yang, Q. Zhang, Till‐Oliver Emde, G. Gaffunder, Carsten Hielscher, Michael P. Lux, Christian Schem, Manfred Welslau, Claudia Schumacher, I. Kuchuk, T Peretz, Larisa Ryvo, R. Yerushalmi, Hee Dong Chae, Y.S. Chae, Seock‐Ah Im, Hwa Jung Kim, Jie‐Hyun Kim, S.-B. Kim, Jung Eun Lee, Y. H. Park, Joohyuk Sohn, Michał Jarząb, Monika Nowaczyk, Zbigniew Nowecki, Tadeusz Pieńkowski, Marek Z. Wojtukiewicz, Piotr J. Wysocki, E. Fomin, I. P. Ganshina, Nikolay Kislov, М. В. Копп, Н. В. Коваленко, Y. Makarova, Marina Matrosova, Р. В. Орлова, Artem Poltoratsky, Р. Р. Сафин, Р. А. Зуков, A. Wong, Yoon Sim Yap, M.A. Coccia-Portugal, Nicolaas H. Fourie, R. Khanyile, L. Schoeman, Ta‐Chung Chao, S.-T. Chen, Wei‐Pang Chung, Yin‐Hsun Feng, Yung‐Chang Lin, Thitiya Dejthevaporn, Napa Parinyanitikul, Chirawadee Sathitruangsak, Areewan Somwangprasert, Piyawan Tienchaianada, Ahmet Alacacıoğlu and 31 more - Journal of Clinical Oncology 2024 cited by 63

  10. 377O A pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with brain metastases (BMs) from DESTINY-Breast (DB) -01, -02, and -03

    Authors: S.A. Hurvitz, Shanu Modi, Wěi Li, Y.H. Park, Wei‐Pang Chung, S-B. Kim, Javier Cortés, Toshinari Yamashita, José Luiz Pedrini, S-A. Im, L-M Tseng, Nadia Harbeck, I. Krop, G. Curigliano, E. Mathias, Jillian Cathcart, A. Cagnazzo, Shahid Ashfaque, Anton Egorov, Fabrice André - Annals of Oncology 2023 cited by 58

  11. Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial

    Authors: Sara A. Hurvitz, S.-B. Kim, Wei‐Pang Chung, Seock‐Ah Im, Y.H. Park, Roberto Hegg, Myoung‐Hwan Kim, Ling-Ming Tseng, Vanessa Petry, C-F. Chung, Hiroji Iwata, E.P. Hamilton, Giuseppe Curigliano, Bo Xu, Anton Egorov, Y. Liu, Jillian Cathcart, Emarjola Bako, Kristen M. Tecson, Sunil Verma, Javier Cortés - ESMO Open 2024 cited by 67

  12. 211MO Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2– locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study

    Authors: M. Martín Jiménez, Elgene Lim, M. Chavez Mac Gregor, Amit Bardia, Jun Wu, Q. Zhang, Zbigniew Nowecki, F. Melo Cruz, Р. Р. Сафин, S-B. Kim, Christian Schem, Alberto J. Montero, Simran Khan, R. Bandyopadhyay, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, P.D. Pérez-Moreno, Joohyuk Sohn - Annals of Oncology 2022 cited by 58

  13. Evidence for Oscillation of Atmospheric Neutrinos

    Authors: Y. Fukuda, T. Hayakawa, E. Ichihara, K. Inoue, K. Ishihara, H. Ishino, Y. Itow, T. Kajita, J. Kameda, S. Kasuga, Kazuyoshi Kobayashi, Yoshiyuki Kobayashi, Y. Koshio, M. Miura, M. Nakahata, S. Nakayama, Atsushi Okada, K. Okumura, N. Sakurai, M. Shiozawa, Y. Suzuki, Y. Takeuchi, Y. Totsuka, S. Yamada, M. Earl, A. Habig, E. Kearns, M. D. Messier, K. Scholberg, J. L. Stone, L. Sulak, C. W. Walter, M. Goldhaber, T. Barszczxak, D. Casper, W. Gajewski, P. G. Halverson, Jonathan Y. Hsu, W. R. Kropp, L. R. Price, F. Reines, M. Smy, H. W. Sobel, M. R. Vagins, K. S. Ganezer, W. E. Keig, R. W. Ellsworth, S. Tasaka, J. Flanagan, A. Kibayashi, J. G. Learned, S. Matsuno, V. J. Stenger, D. Takemori, T. Ishii, J. Kanzaki, T. Kobayashi, S. Mine, K. Nakamura, K. Nishikawa, Y. Oyama, Akito Sakai, M. Sakuda, O. Sasaki, S. Echigo, M. Kohama, Y. Suzuki, T. J. Haines, E. Blaufuss, B. K. Kim, R. Sanford, R. Svoboda, M. L. Chen, Z. Conner, J. A. Goodman, G. W. Sullivan, J. Hill, C. K. Jung, K. Martens, C. Mauger, C. McGrew, E. Sharkey, B. Viren, C. Yanagisawa, W. Doki, K. Miyano, H. Okazawa, C. Saji, M. Takahata, Y. Nagashima, M. Takita, Tomohiro Yamaguchi, M. Yoshida, S. B. Kim, Masato Eto, K. Fujita, T. Hasegawa, T. Hasegawa, S. Hatakeyama, T. Iwamoto and 21 more - Physical Review Letters 1998 cited by 5,093

  14. A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis

    Authors: Adam Brufsky, S.B. Kim, Zanete Zvirbule, Alexandru Eniu, Jeroen Mebis, Joohyuk Sohn, Matthew Wongchenko, Saibah Chohan, Reena Amin, Y. Yan, Virginia McNally, David Miles, Sherene Loi - Annals of Oncology 2021 cited by 88

  15. 181O Interim analysis (IA) of the atezolizumab (atezo) + sacituzumab govitecan (SG) arm in patients (pts) with triple-negative breast cancer (TNBC) in MORPHEUS-pan BC: A phase Ib/II study of multiple treatment (tx) combinations in pts with locally advanced/metastatic BC (LA/mBC)

    Authors: Peter Schmid, Sherene Loi, Luis de la Cruz‐Merino, R. Yerushalmi, S-A. Im, A. Sonnenblick, Maria Martinez‐García, Irene Moreno Candilejo, Liam Kennedy, Kristin Griffiths, Richard B. Schwab, Fiona Young, Linchuan Liao, Kelly DuPree, S-B. Kim - ESMO Open 2024 cited by 20

  16. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

    Authors: Giuseppe Curigliano, Susana Banerjee, Andrés Cervantes, M.C. Garassino, Pilar Garrido, Nicolas Girard, John B.A.G. Haanen, Karin Jordan, F. Lordick, Jean-Pascal Machiels, Olivier Michielin, Solange Peters, Josep Tabernero, Jean-Yves Douillard, George Pentheroudakis, Alfredo Addeo, Laurence Albigès, Paolo A. Ascierto, Susana Banerjee, Fabrice Barlési, Carlos Caldas, Fátima Cardoso, Andrés Cervantes, Iris F. Chaberny, Nathan I. Cherny, Toni K. Choueiri, Melvin L.K. Chua, Carmen Criscitiello, Giuseppe Curigliano, E. de Azambuja, Dirk De Ruysscher, Elisabeth G.E. de Vries, Rebecca Dent, Jean-Yves Douillard, Domenico D’Ugo, Rafał Dziadziuszko, Corinne Faivre‐Finn, Eudald Felip, M.C. Garassino, Pilar Garrido, Nicolas Girard, Rob Glynne‐Jones, V. Golfinopoulos, John B.A.G. Haanen, E. Hamilton, Pasi A. Jänne, Karin Jordan, Ravindran Kanesvaran, S.B. Kim, Uwe G. Liebert, F. Lordick, Jean-Pascal Machiels, Olivier Michielin, T.S.K. Mok, Gilberto Morgan, Radka Obermannová, K. Park, Antonio Passaro, George Pentheroudakis, Solange Peters, Martin Reck, Romane Soler, Florian Scotté, Suresh Senan, Cristiana Sessa, Elizabeth Smyth, Ross A. Soo, Jean‐Charles Soria, Jennifer O. Spicer, Florian Strasser, Josep Tabernero, Dongling Tan, Dario Trapani, Eric Van Cutsem, Henk van Halteren, Paul E. Van Schil, Giulia Veronesi, Jing Yang, Giulia Veronesi, Jing Yang - Annals of Oncology 2020 cited by 313

  17. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial

    Authors: Yeon Hee Park, Tae‐Yong Kim, Gun Min Kim, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee‐Jun Kim, Han Jo Kim, Jong In Lee, Su‐Jin Koh, Ji‐Yeon Kim, Kyung-Hun Lee, Joohyuk Sohn, Sung‐Bae Kim, Jin‐Seok Ahn, Young‐Hyuck Im, Kyung Hae Jung, Seock‐Ah Im, HK Ahn, EK Cho, IH Park, KS Lee, S.H. Sim, S-J Hong, Mei‐Hwei Chang, Jae‐Hong Kim, YJ Kim, Sung‐Han Kim, KJ Suh, YH Park, Woong‐Yang Park, Y-L. Choi, JH Yu, Y-H Im, Ahn Js, Jy Hur, So Hyun Park, JY Kim, SJ Nam, JE Lee, SW Kim, Seung‐Koo Lee, S-A. Im, Myung‐Sun Kim, Tae‐Yop Kim, D-Y. Oh, Tae‐Yop Kim, KH Lee, DW Lee, Hyung Jun Kim, Keun‐Hwa Jung, S-B. Kim, J-H Ahn, JE Kim, JH Jung, SY Kang, MS Ahn, YW Choi, GM Kim, JH Sohn, MH Kim, SJ Koh, JK Cheon, JI Lee, ST Lim, SY Hyun, K.S. Lee, Hyung Jun Kim, M. H. Lee, JH Cho, JH Lim - The Lancet Oncology 2019 cited by 130

  18. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

    Authors: Seock‐Ah Im, Alessandra Gennari, Y.H. Park, Jae Hyoung Kim, Zeping Jiang, Sameer Gupta, Trinugroho Heri Fadjari, Keita Tamura, M.Y. Mastura, Maria Luisa T. Abesamis-Tiambeng, Elaine Hsuen Lim, Ching‐Hung Lin, Aumkhae Sookprasert, Napa Parinyanitikul, Ling‐Ming Tseng, Sang‐Cheol Lee, Priscilla B. Caguioa, Maneesh Singh, Yoichi Naito, Ronald Hukom, BK Smruti, Shoei‐Shen Wang, S.B. Kim, Ki Hoon Lee, Hee Kyung Ahn, Solange Peters, T.W. Kim, Takayuki Yoshino, George Pentheroudakis, G. Curigliano, Nadia Harbeck - ESMO Open 2023 cited by 52

  19. Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial

    Authors: Ye Guo, Myung‐Ju Ahn, Anthony T.�C. Chan, C.-H. Wang, Jin Hyoung Kang, S.-B. Kim, Maximino Bello, Rajender Singh Arora, Q. Zhang, Xiaohui He, P. Li, Arunee Dechaphunkul, Vijay Kumar, K.M. Kamble, W. Li, Alaa Kandil, Ezra E.W. Cohen, Yichao Geng, Eleftherios Zografos, Pingzhang Tang - Annals of Oncology 2019 cited by 58

  20. A Three Dimensional DRAM (3D DRAM) Technology for the Next Decades

    Authors: K. S. Choi, S. H. Kim, J. W. Seo, H. S. Kang, Seung Wan Chu, S. W. Bae, J. H. Kwon, G. S. Kim, Y. T. Park, J. H. Kwak, D. I. Song, S. M. Park, Y. T. Kim, K. C. Jang, J. S. Cho, H. S. Lee, B. H. Lee, J. W. Park, J. H. Lee, H. H. Kwon, D. S. You, C. S. Hyun, J. J. Lee, S. C. Lee, I. D. Kim, J. H. Myung, H. S. Won, J. H. Chun, K. H. Kim, J. H. Kang, S. B. Kim, K. H. Lee, S. O. Chung, S. S. Kim, I. S. Jin, B. K. Lee, C. W. Kim, Joodong Park, S. Y. Cha - IEEE Symposium on VLSI Technology and Circuits (VLSI Technology and Circuits) 2024 cited by 42

  21. Extracting optimization and physical properties of yellowfin tuna (Thunnus albacares) skin gelatin compared to mammalian gelatins

    Authors: Suengmok Cho, Yeun Suk Gu, S.B. Kim - Food Hydrocolloids 2004 cited by 283

  22. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells.

    Authors: Ok‐Hwa Kang, S B Kim, Yun‐Soo Seo, Dae-Ki Joung, Su‐Hyun Mun, Jang‐Gi Choi, Yong Moon Lee, Dianlong Kang, H S Lee, Dong‐Yeul Kwon - 2013 cited by 82

  23. A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases

    Authors: Fabrice André, Javier Cortés, G. Curigliano, S. Modi, Wěi Li, Y.H. Park, W-P Chung, S.-B. Kim, Toshinari Yamashita, José Luiz Pedrini, S-A Im, L-M Tseng, N. Harbeck, Ian E. Krop, S. Nakatani, Kristen M. Tecson, Shahid Ashfaque, Anton Egorov, S.A. Hurvitz - Annals of Oncology 2024 cited by 40

  24. Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life

    Authors: Eric Van Cutsem, Kazuaki Kato, Jaffer A. Ajani, Lin Shen, T. Xia, Ningning Ding, Lu Zhan, Gisoo Barnes, S. B. Kim - ESMO Open 2022 cited by 23